The store will not work correctly when cookies are disabled.
5-fluoro-N-(4-methoxybenzyl)-1H-indazol-3-amine
ID: ALA4866268
PubChem CID: 164621773
Max Phase: Preclinical
Molecular Formula: C15H14FN3O
Molecular Weight: 271.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(CNc2n[nH]c3cc(F)ccc23)cc1
Standard InChI: InChI=1S/C15H14FN3O/c1-20-12-5-2-10(3-6-12)9-17-15-13-7-4-11(16)8-14(13)18-19-15/h2-8H,9H2,1H3,(H2,17,18,19)
Standard InChI Key: ROVPZUBYVUQQES-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
36.8300 -10.3799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8288 -11.1995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5369 -11.6084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5351 -9.9711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2437 -10.3763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2485 -11.1950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0285 -11.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5059 -10.7783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.0208 -10.1189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.1222 -9.9715 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
39.2856 -12.2191 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7423 -12.8296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9993 -13.6053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4537 -14.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7102 -14.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5113 -15.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0554 -14.5381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7960 -13.7654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7693 -15.9288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.2269 -16.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
1 10 1 0
7 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 271.30 | Molecular Weight (Monoisotopic): 271.1121 | AlogP: 3.32 | #Rotatable Bonds: 4 |
Polar Surface Area: 49.94 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.34 | CX LogP: 3.07 | CX LogD: 3.07 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.76 | Np Likeness Score: -1.45 |
References
1. Kwong AJ, Pham TND, Oelschlager HE, Munshi HG, Scheidt KA.. (2021) Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma., 12 (10.0): [PMID:34676038] [10.1021/acsmedchemlett.1c00376] |